NA
COV

Navellier & Associates’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Navellier & Associates’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,342
Closed -$546K – 398
2014
Q4 		$546K Sell
5,342
-44
-0.8% -$4.22K 0.03% 183
2014
Q3 		$466K Sell
5,386
-773
-13% -$68.5K 0.02% 193
2014
Q2 		$555K Sell
6,159
-393
-6% -$29.4K 0.03% 174
2014
Q1 		$483K Sell
6,552
-56
-0.8% -$3.9K 0.02% 184
2013
Q4 		$450K Buy
6,608
+1,248
+23% +$81.2K 0.02% 195
2013
Q3 		$327K Sell
5,360
-345
-6% -$21.1K 0.01% 230
2013
Q2 		$318K Buy
+5,705
New +$330K 0.02% 204

Navellier & Associates's COV Position: Q1 2015 in Review

Navellier & Associates sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 5,342 shares — an estimated $546K sold.

Navellier & Associates first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $555K in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Navellier & Associates reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Navellier & Associates sold 5,342 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $546K.
  • Navellier & Associates first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Navellier & Associates's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $555K in Q2 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Navellier & Associates's 13F filing for Q1 2015, filed 18 May 2015.